openPR Logo
Press release

Substance Use Disorder Market Projected to Reach USD 28.5 Billion by 2034, Growing at 6.8% CAGR

12-12-2025 11:25 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Substance Use Disorder

Substance Use Disorder

Pune, India, December 2025 - The global Substance Use Disorder (SUD) Market is expected to grow from an estimated USD 14.2 billion in 2024 to USD 28.5 billion by 2034, reflecting a CAGR of approximately 6.8% during the forecast period. Market growth is driven by the increasing prevalence of alcohol, drug, and opioid misuse, rising awareness of treatment options, and advancements in therapeutic interventions.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70806

Key Takeaways
• Market Size (2024): USD 14.2 billion
• Forecast Size (2034): USD 28.5 billion
• CAGR (2025-2034): 6.8%
• Dominant Region: North America
• Major Drivers: Rising global substance abuse, expansion of treatment centers, increasing adoption of pharmacological and behavioral therapies, and growing government intervention programs.

Market Overview
Substance Use Disorder (SUD) refers to a condition in which the recurrent use of substances-such as alcohol, opioids, stimulants, or sedatives-causes clinically significant impairment or distress. The market encompasses pharmacological treatments, behavioral therapies, outpatient and inpatient rehabilitation programs, and supportive care services.

Growing awareness, government initiatives, and technological innovations, including digital therapeutics and telemedicine platforms, are improving access to treatment and patient outcomes. Emerging therapies and combination interventions targeting multiple substances are also contributing to market growth.

Market Segmentation
By Treatment Type
• Pharmacological Treatments - Medications for alcohol, opioid, and drug dependence.
• Behavioral Therapy & Counseling - Cognitive-behavioral therapy, motivational interviewing, contingency management.
• Supportive Care - Telehealth, digital therapy apps, monitoring and follow-up solutions.

By Substance
• Alcohol Use Disorder
• Opioid Use Disorder
• Cannabis Use Disorder
• Other Drugs (Stimulants, Sedatives, etc.)

By End User
• Hospitals & Clinics
• Specialty Rehabilitation Centers
• Outpatient Treatment Programs
• Community & Public Health Programs

By Region
• North America: Largest market due to high prevalence, strong treatment infrastructure, and public health initiatives.
• Europe: Steady growth with increasing adoption of pharmacological and behavioral interventions.
• Asia-Pacific: Fastest-growing region due to rising awareness, improving healthcare infrastructure, and government-supported programs.
• Latin America & Middle East/Africa: Emerging markets with expanding treatment access and awareness campaigns.

Explore Full Report here: https://exactitudeconsultancy.com/reports/70806/substance-use-disorder-market

Market Drivers
• Rising incidence of substance abuse across age groups and demographics.
• Expansion of rehabilitation centers and outpatient programs.
• Advancements in pharmacological treatments and behavioral therapy techniques.
• Government initiatives and awareness campaigns promoting prevention and treatment of SUD.

Industry Trends & Opportunities
• Development of digital therapeutics and telehealth platforms for remote monitoring and counseling.
• Increased adoption of combination therapies targeting multiple substances.
• Community-based programs improving access to treatment in high-risk areas.
• Partnerships between pharmaceutical companies, healthcare providers, and governments to expand treatment outreach.

Challenges
• High cost of specialized therapies in some regions.
• Stigma and social barriers limiting treatment uptake.
• Regulatory hurdles for new drugs and digital therapies.
• Need for long-term follow-up to prevent relapse and ensure sustainable recovery.

Conclusion
The Substance Use Disorder Market is projected to witness steady growth over the next decade, driven by rising substance abuse, technological innovation, and increasing access to therapy. Market opportunities lie in pharmacological, behavioral, and digital interventions that enhance patient outcomes and address the global burden of substance use disorders.

This report is also available in the following languages : Japanese (物質使用障害市場), Korean (약물 사용 장애 시장), Chinese (物质使用障碍市场), French (Marché des troubles liés à l'usage de substances), German (Markt für Substanzgebrauchsstörungen), and Italian (Mercato dei disturbi da uso di sostanze), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/70806

Our More Reports:

Gene Therapy In CNS Disorder Market
https://exactitudeconsultancy.com/reports/70794/gene-therapy-in-cns-disorder-market

Alcohol Use Disorder Market
https://exactitudeconsultancy.com/reports/70801/alcohol-use-disorder-market

Opioid Use Disorder Market
https://exactitudeconsultancy.com/reports/70804/opioid-use-disorder-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Substance Use Disorder Market Projected to Reach USD 28.5 Billion by 2034, Growing at 6.8% CAGR here

News-ID: 4313133 • Views:

More Releases from Exactitude Consultancy

Platinum-Based Chemotherapy and Nephrotoxicity Market Projected to Reach USD 3.9 Billion by 2034, Growing at 6.0% CAGR
Platinum-Based Chemotherapy and Nephrotoxicity Market Projected to Reach USD 3.9 …
Pune, India, December 2025 - The global Platinum-Based Chemotherapy and Nephrotoxicity Market is expected to grow from an estimated USD 2.2 billion in 2024 to USD 3.9 billion by 2034, exhibiting a CAGR of approximately 6.0% over the forecast period. The market growth is fueled by the widespread use of platinum-based chemotherapeutics, rising incidence of cancer, and increasing demand for nephroprotective strategies to reduce treatment-associated kidney damage. Download Full PDF Sample
Nasal Polyposis Market Growing at a CAGR of approximately 6.5%
Nasal Polyposis Market Growing at a CAGR of approximately 6.5%
Market Overview The global Nasal Polyposis Market is expanding due to rising prevalence of chronic rhinosinusitis with nasal polyps (CRSwNP), increasing awareness of ENT conditions, and advancements in treatment options. In 2024, the market was valued at approximately USD 6.8 billion and is expected to reach around USD 12.1 billion by 2034, growing at a CAGR of approximately 6.5%. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/70749 Key Market Drivers • Rising Prevalence of
Opioid Use Disorder Market Projected to Reach USD 12.8 Billion by 2034, Growing at 7.5% CAGR
Opioid Use Disorder Market Projected to Reach USD 12.8 Billion by 2034, Growing …
Pune, India, December 2025 - The global Opioid Use Disorder (OUD) Market is expected to grow from an estimated USD 6.0 billion in 2024 to USD 12.8 billion by 2034, reflecting a CAGR of approximately 7.5% during the forecast period. Increasing prevalence of opioid misuse, rising awareness of treatment options, and development of innovative therapies are key factors driving market expansion globally. Download Full PDF Sample Copy of Market Report @
Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Market Forecast 2025-2034
Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Market Forecast 2025-2034
Market Overview The Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Market continues to grow due to rising sinus-related disorders, increasing environmental pollution, and advancements in diagnostic imaging and treatment approaches. In 2024, the global market value was estimated to be over USD 9.5 billion, with expectations to reach approximately USD 16.8 billion by 2034, registering a CAGR of around 6.0%. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/70758 Key Market Drivers • Increasing Prevalence of

All 5 Releases


More Releases for Disorder

Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate? The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to
Autism Spectrum Disorder Therapeutics Market: "Autism Spectrum Disorder Therapie …
Autism Spectrum Disorder Therapeutics Market Scope: Key Insights : Autism Spectrum Disorder Therapeutics Market size was valued at USD 1.92 billion in 2022 and is poised to grow from USD 2.07 billion in 2023 to USD 3.77 billion by 2031, growing at a CAGR of 7.80% during the forecast period (2024-2031). Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/autism-spectrum-disorder-therapeutics-market In-Depth Exploration of the global Autism Spectrum Disorder Therapeutics
Bipolar Disorder Therapeutics Market Report 2024 - Bipolar Disorder Market Oppor …
"The Business Research Company recently released a comprehensive report on the Global Bipolar Disorder Therapeutics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Bipolar Disorder Therapeutics Market: Balancing the Mind - Unveiling Breakthroug …
Allied Market Research recently said Bipolar disorder, a mental health condition characterized by extreme shifts in mood and energy levels, affects millions of people worldwide. The quest for effective therapeutics to manage this complex disorder has seen remarkable progress in recent years. This article explores the innovative developments in bipolar disorder therapeutics, shedding light on the path to achieving a harmonious balance for those living with this condition. ♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞
Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior. Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms